PRECISION VIROLOGICS
Precision’s technology will provide the next-generation vaccines for emerging infectious diseases. PV-ZIKV, our vaccine candidate for Zika, has significant advantages over competitors, including the lack of cross-reactivity among flaviviruses and increased potency
PRECISION VIROLOGICS
Industry:
Biotechnology Commercial Health Care Medical Device
Founded:
2016-01-01
Address:
Saint Louis, Missouri, United States
Country:
United States
Website Url:
http://www.precisionvx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.02 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
Braeburn
Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Immagina Biotechnology
Trento, Italy-based biotech startup
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Bolder Surgical
Bolder Surgical serves health care providers by developing surgical instruments that allow access to confined and delicate structures.
Pandorum Technologies
Bengaluru based biotech startup.
Pr3vent
Eye Care Diagnostic AI Startup
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Precision Virologics
National Institutes of Health
National Institutes of Health investment in Grant - Precision Virologics
Oncolys BioPharma
Oncolys BioPharma investment in Seed Round - Precision Virologics
Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship
Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship investment in Grant - Precision Virologics
